31(top 2%)
papers
1.9K(top 1%)
citations
19(top 2%)
h-index
31(top 2%)
g-index
36
all documents
2.1K
doc citations
777
citing journals

Top Articles

#TitleJournalYearCitations
1Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver DiseaseJAMA Network Open2019230
2Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisMayo Clinic Proceedings2015214
3Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic SteatohepatitisGastroenterology2017209
4ACG Clinical Guidelines: Diagnosis and Management of AchalasiaAmerican Journal of Gastroenterology2020198
5CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in miceHepatology2010163
6Diagnosis and Management of Barrett's Esophagus: An Updated ACG GuidelineAmerican Journal of Gastroenterology2022159
7Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver DiseaseAmerican Journal of Respiratory and Critical Care Medicine2019145
8AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert ReviewClinical Gastroenterology and Hepatology202299
9Microsatellite Instability and Suppressed DNA Repair Enzyme Expression in Rheumatoid ArthritisJournal of Immunology200391
10Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology201585
11The use of high-performance liquid chromatography for quantitation of plasma amino acids in manAnalytical Biochemistry198278
12ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux diseaseNeurogastroenterology and Motility202168
13Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver ForumHepatology201964
14Gut Microbiota-Derived Propionate Regulates the Expression of Reg3 Mucosal Lectins and Ameliorates Experimental Colitis in MiceJournal of Crohn's and Colitis202063
15Long‐term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7‐year results from the PRECiSE 3 studyAlimentary Pharmacology and Therapeutics201462
16Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency VirusClinical Gastroenterology and Hepatology202234
17Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acidAnnals of the New York Academy of Sciences202132
18Salmonella Infection Induces a Hypersecretory Phenotype in Human Intestinal Xenografts by Inducing Cyclooxygenase 2Infection and Immunity200328
19Spermidine Stimulates T Cell Protein-tyrosine Phosphatase-mediated Protection of Intestinal Epithelial Barrier FunctionJournal of Biological Chemistry201327
20Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE TrialsJournal of Crohn's and Colitis201820
21Clinical Research in Hepatology in the COVID‐19 Pandemic and Post‐Pandemic Era: Challenges and the Need for InnovationHepatology202017
22Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican AmericansHepatology Communications202017
23Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative ColitisClinical Gastroenterology and Hepatology202015
24Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE StudyAlimentary Pharmacology and Therapeutics202212
25Refining Noninvasive Diagnostics In Nonalcoholic Fatty Liver Disease: Closing the Gap to Detect Advanced FibrosisHepatology20195
26Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancerCancer Detection and Prevention20043
27Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis BAlimentary Pharmacology and Therapeutics20152
28Editorial: NAFLD in HIV infection - call for action. Authors' replyAlimentary Pharmacology and Therapeutics20152
29Potentially probioticLimosilactobacillus reuterifrom human milk strengthens the gut barrier in T84 cells and a murine enteroid modelJournal of Applied Microbiology20232
30MINDful polypectomy: a quality improvement initiative to improve complete resection of colorectal polypsEndoscopy20151
31Letter: HIV‐associated NAFLD – more questions than answers? Authors’ replyAlimentary Pharmacology and Therapeutics20151
32Mapping the Duodenal Crypt-Villus Transport AxisCellular and Molecular Gastroenterology and Hepatology20181
33Commentary: new tools to assess hepatic steatosis – what do we want to measure? Author's replyAlimentary Pharmacology and Therapeutics20120
34A Pathobiont Fragments Mitochondrial Networks in Epithelial Cells: Implications for Crohn’s DiseaseCellular and Molecular Gastroenterology and Hepatology20210
35Diagnosis and Management of Refractory Gastroesophageal Reflux DiseaseGastroenterology and Hepatology20210
36Response to RajendraAmerican Journal of Gastroenterology20220